Enhanced prevention of progression of non alcoholic fatty liver to steatohepatitis by incorporating pumpkin seed oil in nanoemulsions

Journal of Molecular Liquids

Volumn 225, Issue , 2017, Pages 822-832

  Al Okbi, Sahar Youssef ^a   Mohamed, Doha Abdou ^a   Hamed, Thanaa El Sayed ^a   Kassem, Ahmed Alaa ^a   El Alim, Sameh Hosam Abd ^a   Mostafa, Dina Mahmoud ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Food nanotechnology; Non alcoholic steatohepatitis; Nutraceuticals; Oral nanoemulsions; Percolation phenomenon; Pumpkin seed oil

Indexed keywords

BIOCHEMISTRY; CONTROLLED DRUG DELIVERY; DISEASES; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; PHASE DIAGRAMS; PLANTS (BOTANY); POLYDISPERSITY; RATS; SOLVENTS; TRANSMISSION ELECTRON MICROSCOPY;

FOOD NANOTECHNOLOGIES; NANO-EMULSIONS; NON-ALCOHOLIC STEATOHEPATITIS; NUTRACEUTICALS; PERCOLATION PHENOMENON; PUMPKIN SEED OIL;

OILS AND FATS;

EID: 85006691146     PISSN: 01677322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molliq.2016.10.138     Document Type: Article

References (98)

1. [1] Yao, M., McClements, D.J., Xiao, H., Improving oral bioavailability of nutraceuticals by engineered nanoparticle-based delivery systems. Curr. Nutr. Food Sci. 2 (2015), 14–19.
2. [2] Yao, M., Xiao, H., McClements, D.J., Delivery of lipophilic bioactives: assembly, disassembly, and reassembly of lipid nanoparticles. Annu. Rev. Food Sci. Technol. 5 (2014), 53–81.
3. [3] Porter, C.J., Pouton, C.W., Cuine, J.F., Charman, W.N., Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 60 (2008), 673–691.
4. [4] Dwivedi, P., Khatik, R., Chaturvedi, P., Khandelwal, K., Taneja, I., Raju, K.S., Dwivedi, H., Singh, S.K., Gupta, P.K., Shukla, P., Tripathi, P., Singh, S., Tripathi, R., Wahajuddin, Paliwal, S.K., Dwivedi, A.K., Mishra, P.R., Arteether nanoemulsion for enhanced efficacy against Plasmodium yoelii nigeriensis malaria: an approach by enhanced bioavailability. Colloids Surf. A Physicochem. Eng. Asp. 126 (2015), 467–475.
5. [5] Jadhav, K.R., Shaikh, I.M., Ambade, K.W., Kadam, V.J., Applications of microemulsion based drug delivery system. Curr. Drug Deliv. 3 (2006), 267–273.
6. [6] Ghosh, P.K., Murthy, R.S., Microemulsions: a potential drug delivery system. Curr. Drug Deliv. 3 (2006), 167–180.
7. [7] Mustafa, G., Khan, Z.I., Bansal, T., Talegaonkar, S., Preparation and characterization of oil in water nano-reservoir systems for improved oral delivery of atorvastatin. Curr. Nanosci. 5 (2009), 428–440.
8. [8] Sivakumar, M., Tang, S.Y., Tan, K.W., Cavitation technology - a greener processing technique for the generation of pharmaceutical nanoemulsions. Ultrason. Sonochem. 21 (2014), 2069–2083.
9. [9] Frede, K., Henze, A., Khalil, M., Baldermann, S., Schweigert, F.J., Rawel, H., Stability and cellular uptake of lutein-loaded emulsions. J. Funct. Foods 8 (2014), 118–127.
10. [10] Ahmed, K., Li, Y., McClements, D.J., Xiao, H., Nanoemulsion- and emulsion-based delivery systems for curcumin: encapsulation and release properties. Food Chem. 132 (2012), 799–807.
11. [11] Zheng, J., Li, Y., Song, M., Fang, X., Cao, Y., McClements, D.J., Xiao, H., Improving intracellular uptake of 5-demethyltangeretin by food grade nanoemulsions. Food Res. Int. 62 (2014), 98–103.
12. [12] Koteish, A., Mae Diehl, A., Animal models of steatohepatitis. Best Pract. Res. Clin. Gastroenterol. 16 (2002), 679–690.
13. [13] Mehta, K., Van Thiel, D.H., Shah, N., Mobarhan, S., Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr. Rev. 60 (2002), 289–293.
14. [14] Al-Okbi, S.Y., Mohamed, D.A., Hamed, T.E., Edris, A.E., Potential protective effect of Nigella sativa crude oils towards fatty liver in rats. Eur. J. Lipid Sci. Technol. 115 (2013), 774–782.
15. [15] Qian, Y., Fan, J.-G., Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat. Dis. Int. 4 (2005), 173–177.
16. [16] Assy, N., Kaita, K., Mymin, D., Levy, C., Rosser, B., Minuk, G., Fatty infiltration of liver in hyperlipidemic patients. Dig. Dis. Sci. 45 (2000), 1929–1934.
17. [17] Sass, D.A., Chang, P., Chopra, K.B., Nonalcoholic fatty liver disease: a clinical review. Dig. Dis. Sci. 50 (2005), 171–180.
18. [18] Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 123 (2002), 134–140.
19. [19] Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Zoli, M., Melchionda, N., Metformin in non-alcoholic steatohepatitis. Lancet 358 (2001), 893–894.
20. [20] Egan, M., Prasad, S., PURLs: statins for patients with nonalcoholic fatty liver?. J. Fam. Pract. 60 (2011), 536–538.
21. [21] Laurin, J., Lindor, K.D., Crippin, J.S., Gossard, A., Gores, G.J., Ludwig, J., Rakela, J., McGill, D.B., Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 23 (1996), 1464–1467.
22. [22] Caili, F., Huan, S., Quanhong, L., A review on pharmacological activities and utilization technologies of pumpkin. Plant Foods Hum. Nutr. 61 (2006), 70–77.
23. [23] Ardabili, A.G., Farhoosh, R., Khodaparast, M.H.H., Chemical composition and physicochemical properties of pumpkin seeds (Cucurbita pepo subsp. pepo Var. Styriaka) grown in Iran. J. Agric. Sci. Technol. 13 (2011), 1053–1063.
24. [24] Paris, H.S., Historical records, origins, and development of the edible cultivar groups of Cucurbita pepo (Cucurbitaceae). Econ. Bot. 43 (1989), 423–443.
25. [25] Markovic, V.V., Bastic, L.V., Characteristics of pumpkin seed oil. J. Am. Oil Chem. Soc. 53 (1976), 42–44.
26. [26] Harvath, S., Bedo, Z., Another possibility in treatment of hyperlipidemia with peponen of natural active substance. Fortschr. Med. 89 (1988), 7–8.
27. [27] Schiebel-Schlosser, G., Friederich, M., Phytotherapy of BPH with pumpkin seeds–a multicenter clinical trial. Z. Phys. 19 (1998), 71–76.
28. [28] Zuhair, H.A., Abd El-Fattah, A.A., El-Sayed, M.I., Pumpkin-seed oil modulates the effect of felodipine and captopril in spontaneously hypertensive rats. Pharmacol. Res. 41 (2000), 555–563.
29. [29] Dreikorn, K., The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia. World J. Urol. 19 (2002), 426–435.
30. [30] Al-Okbi, S.Y., Mohamed, D.A., Hamed, T.E., Esmail, R.S., Rice bran oil and pumpkin seed oil alleviate oxidative injury and fatty liver in rats fed high fructose diet. Pol. J. Food and Nutr. Sci. 64 (2014), 127–133.
31. [31] Al-Okbi, S.Y., Mohamed, D.A., Kandil, E., Ahmed, E., Mohammed, S., Functional ingredients and cardiovascular protective effect of pumpkin seed oils. Grasas Aceites 65 (2014), 1–10.
32. [32] Al-Okbi, S.Y., Mohamed, D.A., Kandil, E., Ahmed, E.K., Mohammed, S.E., Antioxidant and anti-cancer effect of egyptian and european pumpkin seed oil. Res. J. Pharm., Biol. Chem. Sci. 7 (2016), 574–580.
33. [33] Mostafa, D.M., Abd El-Alim, S.H., Asfour, M.H., Al-Okbi, S.Y., Mohamed, D.A., Awad, G., Transdermal nanoemulsions of Foeniculum vulgare Mill. essential oil: Preparation, characterization and evaluation of antidiabetic potential. J. Drug Deliv. Sci. Technol. 29 (2015), 99–106.
34. [34] Fouad, S.A., Basalious, E.B., El-Nabarawi, M.A., Tayel, S.A., Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation. Int. J. Pharm. 453 (2013), 569–578.
35. [35] Akhter, S., Jain, G.K., Ahmad, F.J., Khar, R.K., Jain, N., Khan, Z.I., Talegaonkar, S., Investigation of nanoemulsion system for transdermal delivery of domperidone: Ex-vivo and in vivo studies. Curr. Nanosci. 4 (2008), 381–390.
36. [36] Mostafa, D.M., Kassem, A.A., Asfour, M.H., Al Okbi, S.Y., Mohamed, D.A., Hamed, T.E., Transdermal cumin essential oil nanoemulsions with potent antioxidant and hepatoprotective activities: in-vitro and in-vivo evaluation. J. Mol. Liq. 212 (2015), 6–15.
37. [37] Bali, V., Ali, M., Ali, J., Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int. J. Pharm. 403 (2011), 46–56.
38. [38] Bali, V., Ali, M., Ali, J., Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf. A Physicochem. Eng. Asp. 76 (2010), 410–420.
39. [39] Singleton, V.L., Rossi, J.A. Jr., Colorimetry of total phenolics with phosphomolybdic-phosphotungstic acid reagents. Am. J. Enol. Vitic. 16 (1965), 144–158.
40. [40] Jain, K., Kumar, R.S., Sood, S., Gowthamarajan, K., Enhanced oral bioavailability of atorvastatin via oil-in-water nanoemulsion using aqueous titration method. J.Pharm. Sci. Res. 5 (2013), 18–25.
41. [41] Mehta, S.K., Kaur, G., Bhasin, K.K., Incorporation of Antitubercular drug isoniazid in pharmaceutically accepted microemulsion: effect on microstructure and physical parameters. Pharm. Res. 25 (2008), 227–236.
42. [42] Mostafa, D.M., Ammar, N.M., Basha, M., Hussein, R.A., El Awdan, S., Awad, G., Transdermal microemulsions of Boswellia carterii bird: formulation, characterization and in vivo evaluation of anti-inflammatory activity. Drug Deliv. 22 (2015), 748–756.
43. [43] Briggs, G., Williams, M., New mineral mixture for experimental rat diets and evaluation of other mineral mixtures, Federation Proceedings, Federation Amer. Soc. Exp. Biol. 22:2 (1963), 601–608 9650 Rockville Pike, Bethesda, MD 20814-3998.
44. [44] Morcos, S.R., The effect of the protein value of the diet on the neurological manifestations produced in rats by β, β-iminodipropionitrile. Br. J. Nutr. 21 (1967), 269–274.
45. [45] Kawasaki, T., Igarashi, K., Koeda, T., Sugimoto, K., Nakagawa, K., Hayashi, S., Yamaji, R., Inui, H., Fukusato, T., Yamanouchi, T., Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J. Nutr. 139 (2009), 2067–2071.
46. [46] Deminice, R., de Castro, G.S.F., Francisco, L.V., da Silva, L.E.C.M., Cardoso, J.F.R., Frajacomo, F.T.T., Teodoro, B.G., dos Reis Silveira, L., Jordao, A.A., Creatine supplementation prevents fatty liver in rats fed choline-deficient diet: a burden of one-carbon and fatty acid metabolism. J. Nutr. Biochem. 26 (2015), 391–397.
47. [47] Watson, D., A simple method for the determination of serum cholesterol. Clin. Chim. Acta 5 (1960), 637–643.
48. [48] Burstein, M., Scholnick, H.R., Morfin, R., Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11 (1970), 583–595.
49. 2. J. Clin. Chem. Clin. Biochem. 22 (1984), 35–40.
50. [50] Megraw, R.E., Dunn, D., Biggs, H., Manual and continuous-flow colorimetry of triacylglycerols by a fully enzymic method. Clin. Chem. 25 (1979), 273–278.
51. [51] Kei, S., Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta 90 (1978), 37–43.
52. [52] Stepaniak, J.A., Gould, K.E., Sun, D., Swanborg, R.H., A comparative study of experimental autoimmune encephalomyelitis in Lewis and DA rats. J. Immunol. 155 (1995), 2762–2769.
53. [53] Reitman, S., Frankel, S., Colorimetric methods for aspartate and alanine aminotransferase. Am. J. Clin. Pathol. 28 (1957), 55–60.
54. [54] Doumas, B.T., Watson, W.A., Biggs, H.G., Albumin standards and the measurement of serum albumin with bromcresol green. Clin. Chim. Acta 31 (1971), 87–96.
55. [55] Gambino, S.R., Meites, S., (eds.) Standard Methods of Clinical Chemistry, 1965, Academic Press., New York, 55–64.
56. [56] Kochmar, J.F., Moss, D.W., Tietz, N.W., (eds.) Fundamentals of clinical chemistry, 1976, W. B. Saunders and Company, Philadephia, PA., 604.
57. [57] Folch, J., Lees, M., Sloane-Stanley, G., A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226 (1957), 497–509.
58. [58] Cequier-Sánchez, E., Rodriguez, C., Ravelo, A.G., Zárate, R., Dichloromethane as a solvent for lipid extraction and assessment of lipid classes and fatty acids from samples of different natures. J. Agric. Food Chem. 56 (2008), 4297–4303.
59. [59] Patel, A.R., Vavia, P.R., Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 9 (2007), E344–E352.
60. [60] Constantinides, P.P., Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharm. Res. 12 (1995), 1561–1572.
61. [61] Shafiq, S., Shakeel, F., Talegaonkar, S., Ahmad, F.J., Khar, R.K., Ali, M., Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur. J. Pharm. Biopharm. 66 (2007), 227–243.
62. [62] Lawrence, M.J., Rees, G.D., Microemulsion-based media as novel drug delivery systems. Adv. Drug Deliv. Rev. 45 (2000), 89–121.
63. [63] Dixit, A.R., Rajput, S.J., Patel, S.G., Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS PharmSciTech 11 (2010), 314–321.
64. [64] Vyas, S.P., Khar, R.K., Submicronemulsions. Vyas, S.P., Khar, R.K., (eds.) Targeted and Controlled Drug Delivery: Novel Carrier Systems, 2002, CBS Publishers, New Delhi, 280–302.
65. [65] Sukanaya, G., Mantry, S., Anjum, S., Review on nanoemulsions. Int. J. Pharm. Sci. Res. 1 (2013), 192–205.
66. [66] Xia, B., Ha, W., Meng, X., Govender, T., Peng, S., Ding, L., Li, B., Zhang, S., Preparation and characterization of a poly(ethylene glycol) grafted carboxymethyl konjac glucomannan copolymer. Carbohydr. Polym. 79 (2010), 648–654.
67. [67] Tadros, T., Izquierdo, P., Esquena, J., Solans, C., Formation and stability of nano-emulsions. Adv. Colloid Interf. Sci. 108–109 (2004), 303–318.
68. [68] Vujasinovic, V., Djilas, S., Dimic, E., Basic, Z., Radocaj, O., The effect of roasting on the chemical composition and oxidative stability of pumpkin oil. Eur. J. Lipid Sci. Technol. 114 (2012), 568–574.
69. [69] Andjelkovic, M., Van Camp, J., Trawka, A., Verhé, R., Phenolic compounds and some quality parameters of pumpkin seed oil. Eur. J. Lipid Sci. Technol. 112 (2010), 208–217.
70. [70] Vujasinovic, V., Djilas, S., Dimic, E., Romanic, R., Takaci, A., Shelf life of cold-pressed pumpkin (Cucurbita pepo L.) seed oil obtained with a screw press. J. Am. Oil Chem. Soc. 87 (2010), 1497–1505.
71. [71] Huang, D., Ou, B., Prior, R.L., The chemistry behind antioxidant capacity assays. J. Agric. Food Chem. 53 (2005), 1841–1856.
72. [72] Górnaś, P., Dwiecki, K., Siger, A., Tomaszewska-Gras, J., Michalak, M., Polewski, K., Contribution of phenolic acids isolated from green and roasted boiled-type coffee brews to total coffee antioxidant capacity. Eur. Food Res. Technol. 242 (2016), 641–653.
73. [73] Hathout, R.M., Woodman, T.J., Mansour, S., Mortada, N.D., Geneidi, A.S., Guy, R.H., Microemulsion formulations for the transdermal delivery of testosterone. Eur. J. Pharma. Sci. 40 (2010), 188–196.
74. [74] Mehta, S.K., Kaur, G., Bhasin, K.K., Analysis of tween based microemulsion in the presence of TB drug rifampicin. Colloids Surf. A Physicochem. Eng. Asp. 60 (2007), 95–104.
75. [75] Mehta, S.K., Bala, K., Tween-based microemulsions: a percolation view. Fluid Phase Equilib. 172 (2000), 197–209.
76. [76] Grest, G.S., Webman, I., Safran, S.A., Bug, A.L.R., Dynamic percolation in microemulsions. Phys. Rev. A 33 (1986), 2842–2845.
77. [77] Bennett, K.E., Hatfield, J.C., Davis, H.T., Macosko, C.W., Scriven, L.E., Viscosity and conductivity of microemulsions. Robb, I.D., (eds.) Microemulsions, 1982, Springer US, Boston, MA, 65–84.
78. [78] Djordjevic, L., Primorac, M., Stupar, M., Krajisnik, D., Characterization of caprylocaproyl macrogolglycerides based microemulsion drug delivery vehicles for an amphiphilic drug. Int. J. Pharm. 271 (2004), 11–19.
79. [79] Mo, C., Li, X., Microstructure and structural transition in coconut oil microemulsion using semidifferential electroanalysis. J. Colloid Interface Sci. 312 (2007), 355–362.
80. [80] Florence, A.T., Attwood, D., Emulsions, suspensions and other dispersions. Florence, A.T., Attwood, D., (eds.) Physicochemical Principles of Pharmacy, 1998, Macmillan Press Ltd, London, 252–307.
81. ®–isopropyl myristate microemulsions using different experimental methods. Int. J. Pharm. 276 (2004), 115–128.
82. [82] Qian, C., McClements, D.J., Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocoll. 25 (2011), 1000–1008.
83. [83] Ghosh, V., Mukherjee, A., Chandrasekaran, N., Ultrasonic emulsification of food-grade nanoemulsion formulation and evaluation of its bactericidal activity. Ultrason. Sonochem. 20 (2013), 338–344.
84. [84] Kassem, A.A., Mohsen, A.M., Ahmed, R.S., Essam, T.M., Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: design, optimization, in vitro and in vivo evaluation. J. Mol. Liq. 218 (2016), 219–232.
85. [85] Muller, R.H., Zeta Potential and Particle Charge in Laboratory Practice: Introduction to Theory, Practical and Data Interpretation. 1996, Wissenschaftliche Verlagsgesellschaft, Stuttgart, 104–108.
86. [86] Sari, T.P., Mann, B., Kumar, R., Singh, R.R.B., Sharma, R., Bhardwaj, M., Athira, S., Preparation and characterization of nanoemulsion encapsulating curcumin. Food Hydrocoll. 43 (2015), 540–546.
87. [87] Klang, V., Valenta, C., Lecithin-based nanoemulsions. J. Drug Deliv. Sci. Tech. 21 (2011), 55–76.
88. [88] Chhabra, G., Chuttani, K., Mishra, A.K., Pathak, K., Design and development of nanoemulsion drug delivery system of amlodipine besilate for improvement of oral bioavailability. Drug Dev. Ind. Pharm. 37 (2011), 907–916.
89. [89] Ghoshal, A.K., New insight into the biochemical pathology of liver in choline deficiency. Crit. Rev. Biochem. Mol. Biol. 30 (1995), 263–273.
90. [90] Vetelainen, R., van Vliet, A., van Gulik, T.M., Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J. Gastroenterol. Hepatol. 22 (2007), 1526–1533.
91. [91] Al-Humadi, H., Theocharis, S., Dontas, I., Stolakis, V., Zarros, A., Kyriakaki, A., Al-Saigh, R., Liapi, C., Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases. Dig. Dis. Sci. 57 (2012), 3168–3177.
92. [92] Tahan, V., Eren, F., Avsar, E., Yavuz, D., Yuksel, M., Emekli, E., Imeryuz, N., Celikel, C., Uzun, H., Haklar, G., Tozun, N., Rosiglitazone attenuates liver inflammation in a rat model of nonalcoholic steatohepatitis. Dig. Dis. Sci. 52 (2007), 3465–3472.
93. [93] Lim, J.S., Mietus-Snyder, M., Valente, A., Schwarz, J.M., Lustig, R.H., The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat. Rev. Gastroenterol. Hepatol. 7 (2010), 251–264.
94. [94] Armutcu, F., Coskun, O., Gurel, A., Kanter, M., Can, M., Ucar, F., Unalacak, M., Thymosin alpha 1 attenuates lipid peroxidation and improves fructose-induced steatohepatitis in rats. Clin. Biochem. 38 (2005), 540–547.
95. [95] Tian, Y.F., He, C.T., Chen, Y.T., Hsieh, P.S., Lipoic acid suppresses portal endotoxemia-induced steatohepatitis and pancreatic inflammation in rats. World J. Gastroenterol. 19 (2013), 2761–2771.
96. [96] Yang, S., Zhu, H., Li, Y., Lin, H., Gabrielson, K., Trush, M.A., Diehl, A.M., Mitochondrial adaptations to obesity-related oxidant stress. Arch. Biochem. Biophys. 378 (2000), 259–268.
97. [97] Rezig, L., Chouaibi, M., Msaada, K., Hamdi, S., Chemical composition and profile characterisation of pumpkin (Cucurbita maxima) seed oil. Ind. Crop. Prod. 37 (2012), 82–87.
98. [98] Tamilvanan, S., Formulation of multifunctional oil-in-water nanosized emulsions for active and passive targeting of drugs to otherwise inaccessible internal organs of the human body. Int. J. Pharm. 381 (2009), 62–76.